Nelson Dusetti: Next week I’ll be in Tenerife for the PAMM-EORTC Meeting
Nelson Dusetti, Head of the Department of Translational Research and Innovative Therapies at the CRCM, shared PAMM – Pharmacology and Molecular Mechanisms Group’s post on LinkedIn:
“Next week I’ll be in Tenerife for the PAMM-EORTC Meeting!
I’m honored to be one of the keynote speakers and to share our work on tumor heterogeneity and therapeutic resistance in pancreatic cancer. Key challenges we must overcome to bring truly personalized treatment strategies to patients.
I’ll present insights from our translational research program at the CRCM – Marseille Cancer Research Center and Paoli-Calmettes Institute, including the development of AI-driven molecular signatures and functional models to guide therapy selection.
Looking forward to seeing many colleagues there and exchanging ideas to push the field forward!”
Quoting PAMM’s post on LinkedIn:
“Meet our Keynote Speakers at the PAMM-EORTC in Tenerife!
Proud to welcome Dr Nelson Dusetti (France) on Tumor heterogeneity and resistance as key challenges for advancing personalized therapeutic strategies in pancreatic cancer!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023